PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-May-2025 Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement Secarna Pharmaceuticals GmbH & Co. KG
12-May-2025 Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate Thermosome
12-May-2025 Kroyf Labcorp Expands Its Presence as Leading Pharma Franchise Company in Panchkula Kroyf Labcorp
12-May-2025 AEVIS VICTORIA SA – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025. AEVIS VICTORIA SA
12-May-2025 Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
12-May-2025 Formycon reports strong operational performance and financial results for first quarter of 2025 Formycon AG
09-May-2025 Lonza Announces Results of the 2025 Annual General Meeting – All Motions Proposed by Board of Directors Approved Lonza Group AG
09-May-2025 Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX Drägerwerk AG & Co. KGaA
09-May-2025 Lonza Q1 2025 Qualitative Update: Strong Performance Across All Businesses in Line with Expectations for Full-Year 2025 Lonza Group AG
08-May-2025 DocMorris AG shareholders approve capital increase and all proposals put forward by the Board of Directors DocMorris AG
08-May-2025 Marinomed Biotech AG announces results for the first quarter of 2025 Marinomed Biotech AG
08-May-2025 RHÖN-KLINIKUM AG holds steady course in first quarter of 2025 – outlook confirmed RHÖN-KLINIKUM Aktiengesellschaft
08-May-2025 DocMorris announces final details on the agenda of today's Annual General Meeting and the planned capital increase DocMorris AG
08-May-2025 Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited
07-May-2025 Annual General Meeting of SKAN Group AG approves all proposals SKAN AG
07-May-2025 Medacta announces the results of today's Annual General Meeting Medacta Group SA
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
07-May-2025 Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences Formycon AG
07-May-2025 Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments Evotec SE
07-May-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network: Revenue up 21.4% in the first quarter of 2025. The integrations of Spital Zofingen and CentroMedico are bearing fruit. AEVIS VICTORIA SA